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ABSTRACT The functional imaging of neuronal circuits of the central nervous system is crucial for phenotype screenings or
investigations of defects in neurodegenerative disorders. Current techniques yield either low penetration depth, yield poor reso-
lution, or are restricted by the age of the animals. Here, we present a novel ultramicroscopy protocol for ﬂuorescence imaging and
three-dimensional reconstruction in the central nervous system of adult mice. In combination with tracing as a functional assay for
axonal transport, retrogradely labeled descending motor neurons were visualized with>4 mm penetration depth. The analysis of
the motor cortex shortly before the onset of clinical prion disease revealed that >80% neurons have functional impairments in
axonal transport. Our study provides evidence that prion disease is associated with severe axonal transport defects in the cortical
motor neurons and suggests a novel mechanism for prion-mediated neurodegeneration.INTRODUCTION
Visualization of large areas in the central nervous system
(CNS) is required for a wide range of studies including pheno-
type screenings, studies of neuronal circuits, or studies of
transport processes in neuronal projections. Axonal transport
plays a crucial role in neuron viability and differentiation (1)
and is impaired at different neurodegenerative disorders, such
as amyotrophic lateral sclerosis, Huntington’s disease, or Alz-
heimer’s disease (1–3). A powerful method to investigate the
transport in neuronal projections is retrograde axonal tracing
labeling neurons often located in large CNS areas. The
imaging combining deep specimen penetration with high
resolution is still not achieved. Confocal, electron micros-
copy, and objective-coupled planar illumination microscopy
(4) keep high resolution at penetration depths of up to
0.15 mm. Histological sectioning necessary for investigations
of larger CNS areas produce side effects causing information
loss and compromising three-dimensional (3D) reconstruc-
tion (5). Magnetic resonance imaging, ultrasound imaging,
optical coherence, and optical projection tomography reveal
deeper penetration but do not yield cellular resolution (6).
Ultramicroscopy is a method using an orthogonal thin light
sheet to visualize macroscopic specimens (7). Two types of
optical layouts apply cylindrical lenses to focus an expanded
laser beam into a light sheet. The simpler version overlaps the
light sheet with the imaging plane of a microscope objective
(8). Another version utilizes laser excitation from two
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0006-3495/09/04/3390/9 $2.00opposing sides to reduce shadowing artifacts (9,10). The latter
setup combined with procedure to clear brain tissues (11)
achieved 2 mm penetration for mouse embryos or 0.41 mm
for 35-day-old mice (9). The dependence on green fluorescent
protein (GFP) expression and age limitations of the clearing
efficacy restricted the method application to young animals.
Prion diseases, e.g., bovine spongiform encephalopathy in
cattle and Creutzfeldt-Jakob disease (CJD) in humans, are fatal
neurodegenerative disorders of the CNS. The clinical symp-
toms include motor dysfunctions and dementia (12). Spongio-
sis, neuronal cell loss, microglial activation, and proliferation
of astrocytes are typical neuropathological hallmarks (13).
The defects in axonal functions in vivo (14–16) and in vitro
(17) were also reported as possible factors for the clinical
manifestation of the disease. The role of spinal cord transport
pathways in prion pathogenesis was implicated by the study on
transgenic mice expressing the truncated prion protein. These
mice did not demonstrate any detectable pathological changes
in the brain, but did show prion-induced loss of motor neurons
in the spinal cord (18). Other reports, however, implied that
prion disease is independent of the neuronal transport (19,20).
In this work, we report novel ultramicroscopy setup,
which achieves penetration depths of up to 4.2 mm in adult
mouse brain and spinal cord specimens. Combining this
powerful imaging technique with the tracing as a functional
assay for the axonal transport, we show that 78–98% of
motor cortex (MC) neurons reveal impaired axonal transport
at the onset of clinical prion disease.
MATERIAL AND METHODS
Mouse inoculation and AAV application
All the procedures with laboratory animals were approved by the committee
for the Care and Use of Laboratory Animals by the State of Bavaria,
doi: 10.1016/j.bpj.2009.01.032
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Le Genest Saint Isle, France; Tga20 transgenic mice, which express 10-fold
PrP protein as compared with the wt (21). The animals were challenged with
the Rocky Mountain Laboratory (RML) prion strain. The inoculum con-
sisted of a 1% (w/v) brain homogenate from terminally scrapie-sick CD1
mice infected with the RML prion strain.
Animals were inoculated with 1 ml of either 1% (w/v) of RML prions or
with 1% brain homogenate from healthy littermates (mock) into right sciatic
nerve (i.n.) as previously described (22). In brief, animals were anesthetized
with 40 mg/kg Ketanest (Parke-Davis, c/o Pfeizer, Freiburg, Germany) and
40 mg/kg Rompun (Bayer, Leverkusen, Germany). The right sciatic nerve
was surgically exposed by dislodging Musculus gluteus superficialis and
Musculus biceps femoris, placed onto a metal plate (2  5  1 mm) and
prion inoculate was applied with 33-gauge Hamilton syringe over a period
of 5 min. After inoculation, the sciatic nerve was repositioned and the wound
was closed with Vicryl resorbable sutures (Johnson & Johnson, Duesseldorf,
Germany).
Single-stranded adeno-associated virus (AAV) is widely used as a retro-
grade delivery system in mice and rats (23–26). It is also used to express
AAV-CNTF-GFP or AAV-BDNF-GFP (27). The distribution of transgenic
AAV in CNS and transport along neuronal projections was also extensively
studied (28–30). Also the internalization as well as transport properties of
AAVs are well investigated, which is reviewed elsewhere (31,32). Deletion
of terminal resolution site in AAV results in the generation of a double-
stranded AAV vector. Modified double-stranded AAVs are also used as
a delivery system. They possess essentially the same transport properties,
but higher speed of transgene delivery and expression (33). A modified
AAV type 2 vector expressing DsRed-Express (AAV-REx) was used to
target neurons in the cortico- and rubrospinal tract. Before the onset of clin-
ical scrapie mice were anesthetized with ketanest/rompun, a cut was made on
the level of the cervical spinal cord and 1  108 genome containing AAV
particles were inoculated in a total volume of 1 ml into the cervical spinal
cord with a 33-gauge Hamilton syringe over the period of 2 min. After inoc-
ulation, the wound was closed with Vicryl resorbable sutures (Johnson and
Johnson, Duesseldorf, Germany).
Sample preparation
At the terminal stage of the prion disease, animals were sacrificed using
an overdose of Ketanest/Rompun and transcardially perfused with PBS
followed with 4% paraformaldehyde in sodium-phosphate buffer (pH 7.2).
Brains and spinal cords were removed and postfixed in 4% paraformalde-
hyde for 1 h at 4C. Brain and spinal cord samples for ultramicroscopy
were washed for 2 h in phosphate-buffered saline (PBS) and subsequently
in 30%, 50%, 70%, 80%, 96%, and two times in 100% alcohol 10 h each
at room temperature. The specimens were prepared by excising the area of
interest. After 1 h incubation in n-hexane (Sigma, Taufkirchen, Germany)
the samples were transferred into clearing solution (CS) composed of one
part of benzyl alcohol and two parts of benzyl benzoate, both from Sigma
(9). To avoid air contact, because it showed to affect the clearing procedure,
n-hexane was substituted with CS in 3–4 steps for 20–30 min each. After-
ward, the sample was incubated in pure CS for 14–18 h at room temperature.
The samples for confocal microscopy were postfixed in 4% paraformalde-
hyde for 1 h at 4C and incubated into 20% sucrose in PBS for cryoprotec-
tion for overnight at 4C. Subsequently, the samples were frozen in Tissue
Tek (Sakura, Zoeterwoude, Netherlands), and 20 mm-thick cryosections
were made for confocal microscopy analysis.
Ultramicroscopy
The SPIM (selective plane illumination microscopy) or ultramicroscopy
setup had an optical excitation path similar to those previously reported
(8,34,35). The major differences included a high-power 8W Ar Ion Laser
(Innova I-308, Coherent, Santa Clara, CA) and an objective inverter
(LSM Tech, Stewartstown, PA) built into a commercial inverted microscope
(Axiovert 200, Zeiss, Goettingen, Germany). The laser excitation beam(diameter 4 mm) was expanded 3.3-fold using a telescope (Thorlabs, Auburn,
CA). A 10 mm-tall (with focus beam waist of 3–4 mm) light sheet was created
by focusing the beam with a cylindrical lens (focal length 5 cm, Newport, Ir-
vine, CA). It was adjusted exactly along the focus plane of a microscope
objective by tilting the input angle of the excitation beam and positioning
it exactly into the center of cylindrical lens with a mirror (Thor Labs, Auburn,
CA). To focus the light sheet exactly on the specimen, the cylindrical lens
was moved using a translation stage (Standa, Vilnius, Lithuania).
Epiplan 10X with 0.2 numerical aperture (NA) and LD Achroplan 20with
0.4 NA objectives (Zeiss, Goettingen, Germany) were used in this work. They
were placed 14 mm and 6 mm from a home-built sample chamber, respec-
tively. The sample chamber was made of 36  25 mm rectangular 0.4 mm-
thick cover glasses (Paul Marienfeld GmbH, Lauda-Koenigshofen, Germany)
glued together with fast-drying acrylamide glue (Pattex, Henkel, Duesseldorf,
Germany). After sample fixation and clearing (see ‘‘Sample preparation’’), the
specimen was affixed with acrylamide glue (Pattex, Henkel, Duesseldorf,
Germany) to a home-built glass rod. The sample was positioned with a stepper
motor-controlled stage located above the sample chamber (Standa, Vilnius,
Lithuania). The stage enabled XY and rotational step motion with XY accu-
racy of 0.1 mm and rotational accuracy of 0.1 and also including a feed-
back-memory system. The stepper motors were controlled by the software
package LabView (National Instruments, Austin, TX).
The emission light was directed from the objectives to the microscope via
an objective inverter system allowing a flexible horizontal positioning of the
objective at a greater distance and range than in an inverted microscope
(LSM Tech, Stewartstown, PA). This setup enabled microscope to be
precisely visually focused. The same beam path and filtering optics were
used for visual observation and for the camera.
The emission light beam from the objective inverter went through
a dichroic mirror (DCLP 555, Chroma, Rockingham, VT) and then through
a band pass filter (HQ 607/75, Chroma) to remove any scattered excitation
light from the laser. A back-illuminated electron multiplying charge-coupled
device (EMCCD) camera with resolution of 512  512 pixels, 16 mm/pixel
(Cascade II, Photometrics, Tucson AZ) was used in this work.
Laser illumination was synchronized with EMCCD camera exposure, as
previously reported (35,36) to minimize illumination time and, conse-
quently, photobleaching of the probe. The exposure time for image acquisi-
tion was 500 ms per frame. The synchronization of laser illumination and
EMCCD camera exposure was administered by a solid-state electronically
tunable acousto-optic filter (AOTF, AA Sa, Orsay, France). Electronic
output signal from the EMCCD camera was filtered and temporally read-
justed using a function generator (Hameg, Mainhausen, Germany).
Data acquisition and storage were administered by the software package
MetaMorph 7.1 (Molecular Devices, Downingtown, PA).
Confocal microscopy
Serial 20 mm-thick cryosections were performed for the whole MC area of
prion- and mock-challenged mice. Every third section was taken for anatom-
ical analysis and confocal imaging. A series of five from selected sections
were anatomically localized in the same MC region (evaluated region length
260 mm) for all studied samples. Serial confocal Z-stacks were taken with
a step of 1 mm on a Leica SP5 laser-scanning confocal microscope (Leica,
Mannheim, Germany) with a 20 (NA 0.7) immersion objective. The fluo-
rescence emission of REx resulted from excitation from a 514 nm laser and
was detected with 580–620 nm spectral band width on Leica TCS SP5
scanner and LAS AF software (Leica, Mannheim, Germany). Z-stacks
were combined and processed with ImageJ software package (Psion Image,
National Institutes of Health, Bethesda, MD).
Multiphoton microscopy
Multiphoton experiments were carried out using a specialized two-photon
microscope that was customized in collaboration with the manufacturer on
a commercial scanning system (TriMScope, LaVision BioTec, Bielefeld,
Germany). We used photomultipliers (PMTs; Hamamatsu PhotonicsBiophysical Journal 96(8) 3390–3398
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a single beam for excitation (37).
Two modules each comprising four detector PMTs in nondescanned
arrangement were used for the single-beam mode allowing simultaneous
signal acquisition in forward as well as backward direction. Switchable
dichroic mirrors and band pass filters were used to separate the signals before
each PMT. A Ti:Sapphire laser (Chameleon, Coherent, Santa Clara, CA) and
an optical parametric oscillator (OPO; APE, Berlin, Germany) were coupled
into the scan head via two separate ports, and both were directed through two
independent prechirp paths consisting of two prisms to compensate pulse
broadening due to the intermediate optics and the objective lens. To mini-
mize losses, all optical elements in the OPO beam pathway including tube
and objective lens were adapted for high transmission and wavelength
correction. The wavelength tuning was completely automated by the Im-
Spector scanner software (Max-Planck Institute for Biophysical Chemistry,
Goettingen, Germany) allowing 2-photon excitation and emission spectrom-
etry within short time ranges (37).
Both infra-red laser beams were overlapped on a short-pass dichroic
mirror (DCSP 750, Chroma) for reflecting the scanning excitation beams
into the objective (20 0.95 W IR, Olympus Deutschland, Hamburg,
Germany) and on the sample, and also to allow the transmission of the fluo-
rescence to the detectors. The OPO was set to 1100 nm to specifically excite
the REx. A band pass filter (HQ 620/60M, Chroma) was used to block out
auto fluorescence and to specifically detect the REx. 512 512 pixel images
for 500 mm  500 mm image field were scanned at 800 lines/second in
Z-stack steps of 3 mm.
Image analysis and quantiﬁcation of neurons
and REx-positive cells
Z-projection of each confocal stack was done on ImageJ software package
(Psion Image). Obtained Z-projections for each side of M were combined
in Adobe Photoshop (Adobe Systems, Munich, Germany) to obtain
complete picture of tracer-positive neurons on the given side of given
section. Obtained images were combined in one stack for each mouse and
then in one file for simultaneous thresholding and quantification.
Ultramicroscopy stacks for the quantification were kept 250 mm thick and
anatomically localized to match the anatomical region similar to the one
evaluated by confocal microscopy. They were initially contrasted to remove
background and leave only tracer-positive objects. Subsequently, all the
stacks were combined in one file similar to the confocal one.
REx-positive cells were quantified with ImageJ software package (Psion
Image). The mask parameter for counting was adjusted so that the number of
AAV-REx-positive objects correlated with the number of PGP9.5-stained
neurons in the same MC region of mock-inoculated animals. All statistical
analyses were done using Prism software (GraphPad Software, San Diego,
CA).
The ultramicroscopy stacks of MC were analyzed with Volocity software
package (Improvision, Tu¨bingen, Germany) where it is indicated. The fluo-
rescent objects having the brightness between 40% and 100% were selected,
and the objects larger than 200 mm3 were filtered out. The three-dimensional
coordinates obtained in this analysis were transferred to MATLAB software
(The MathWorks, Munich, Germany) to make 3D reconstruction of AAV-
REx positive cells in MC.
As an internal control experiment, Ni2þ-NTA agarose beads (QIAGEN, Hil-
den, Germany) were coated with his6-tagged DsRed protein (35), washed, and
briefly centrifuged. The DsRed coated beads were imbedded in 1% low-melting
agarose (Roth, Karlsruhe, Germany) and imaged with ultramicroscopy, multi-
photon microscopy, and confocal microscopy under the same imaging and
sample clearing conditions that were used for the imaging of REx-positive
MC neurons. Because the confocal imaging was performed on thin cryosec-
tions in this study, the DsRed coated beads were also imaged on the surface
of a cover glass. These experiments revealed that the relative fluorescence inten-
sities are similar for the multiphoton and confocal imaging methods, but
1.5-fold higher for the ultramicroscopy (Supporting Material, Fig. S1).Biophysical Journal 96(8) 3390–3398Immunohistochemistry and PET-blots
For immunohistochemistry, 20 mm cryosections were used. The antibodies
used were: mouse monoclonal anti-NeuN (working concentration: 33 mg/ml,
Millipore, Schwalbach, Germany) and rabbit polyclonal anti-PGP9.5
(working concentration: 16mg/ml, Abcam, Cambridge, UK). NeuN was visu-
alized with biotin-SP-conjugated AffiniPure rabbit anti-mouse IgG (1:100,
Dianova, Hamburg, Germany) combined with Cy5-conjugated streptavidin
(1:100, Dianova). PGP9.5 was visualized with goat anti-rabbit IgG (1:100,
Dianova) combined with Cy5-conjugated streptavidin (1:100, Dianova).
The paraffin-embedded tissue blot (PET-blot) method was used to visu-
alize the prions in the brain tissues. PET-blot was performed as previously
described elsewhere (38,39) with minor changes. Briefly, 5 mm-thick
paraffin sections were transferred onto 0.45 mm pore nitrocellulose
membranes (Schleicher und Schuell, Dassel, Germany), treated with
Proteinase K (Roche Applied Sciences, Mannheim, Germany), and PrPSc
was detected using the mouse monoclonal anti-PrP 6H4 antibody (Prionics,
Schlieren, Switzerland).
The localization of prions on 20 mm-thick cryosections was done using
polyclonal rabbit anti-PrP antibodies produced in our laboratory (R340)
with the working concentration of 33 mg/ml. They were visualized with bio-
tinylated goat anti-rabbit IgG (1:100, Dianova) combined with Cy5-conju-
gated streptavidin (1:100, Dianova). To remove the host PrP, the sections
were treated with 100% formic acid for 8 min before antibody treatment.
The mock controls were always stained in the same experiment with the
sections from prion-infected animals.
RESULTS
Axonal tracing as a functional assay for axonal
transport upon prion challenge
Retrograde tracing as an assay for axonal transport was per-
formed with a viral vector system based on the AAV type 2
(25) expressing the fluorescent marker DsRed-Express
(REx). After injection into the spinal cord, AAV is retro-
gradely transported along axons, and REx expression labels
the bodies of neurons in the spinal cord and several brain
regions, including the red nucleus (RN) and MC, which
we analyzed in this study. Prion inoculation into the right
sciatic nerve results in the initially asymmetrical PrPSc accu-
mulation in the RN and MC on the side contralateral to the
inoculation. At the onset of clinical disease, the PrPSc is
bilaterally localized in different CNS centers including spinal
cord, RN, and MC (22,40). To investigate whether the
axonal transport in cortico- and rubrospinal neurons is
involved in prion pathogenesis, we applied AAV-REx to
label the RN, MC, and gray matter in the cervical spinal
cord cranially to the site of application (Fig. 1 A). Either
C57Bl/6 wt or transgenic mice (Tga20) were used for tracer
application at 136 and 54 days after prion infection, respec-
tively. This time point is a few days before the onset of
clinical disease, which allowed us to associate observed
molecular effects with the onset of clinical disease symp-
toms, such as ataxia and partial paralysis of hind limbs.
Improved sample preparation and imaging
We improved CNS imaging with optimized specimen
preparation and clearing procedures as well as a superior
Ultramicroscopy: Prion-Induced Effects 3393ultramicroscopy setup. The specimens were prepared to
maximally expose the area of interest. They were removed
from the CS before reaching the state of complete clearance.
Longer incubation times turned out to reduce the fluorescence
and, as a consequence, seriously diminish signal/background.
Clearing of brain samples was consistent for the animals aged
between 180 and 400 days. Our ultramicroscopy setup
(Fig. 1 B) relied on the one-sided single-beam version,
because the fluorescence intensity across cleared tissues
remained constant. High-power lasers; a tightly focused and
high-intensity light sheet; a high-sensitivity and low-noise
EMCCD camera; and a motorized, direct sample positioning
device further contributed for the enhanced performance of
this simple, yet high-resolution and deep penetration imaging
system.
The improved ultramicroscopy protocol enabled us for the
first time to visualize REx-positive neurons with 0.3 mm-deep
penetration in the spinal cord (Fig. 1 C and Movie S1, 264-
day-old Tga20 mouse). The brain tissue in RN was somewhat
denser than in spinal cord; however, 0.2–0.3 mm deep pene-
tration depth could be achieved for mice 200–396 days of age
(Fig. 1 D, 225-day-old Tga20 mouse). Moreover, imaging in
MC was accomplished with a penetration depth of 4.2 mm in
273-day-old wt mouse. Minor contrasting was required for
quick and robust 3D reconstruction of the entire MC (Fig. 1D
and Movie S2). Achievement of such penetration depths
establishes ultramicroscopy as a powerful tool for imaging
neurons in large CNS areas with cellular resolution.
Axonal tracing and imaging in the RN
Large pyramidal neurons in the RN were located in an area of
0.2–0.35 mm diameter. Ultramicroscopy imaging showed
bright and clearly recognizable neurons (Fig. 2 A, 396-day-
old wt mouse) with resolution comparable to the confocalimaging (Fig. 2 B, 242-day-old wt mouse). The signal/back-
ground of ultramicroscopy images were comparable to the
confocal microscopy, but the uniform background (the devia-
tion between maximal and minimal background brightness
only 1.2  0.1-fold) allowed us to obtain clear images and
to generate a robust 3D reconstruction. Such reconstructions
resulted in important information on neuron location observed
at different angular views (Fig. 2 C, the same specimen as in
Fig. 2 A). In contrast to ultramicroscopy, the background
of confocal images was extremely variable, differing by
67.5-  7.7-fold, which makes them more difficult to process
and analyze. Moreover, the cryosectioning caused artifacts,
which also compromised 3D reconstruction. Because the sec-
tions were acquired independently, it was impossible to exactly
position them to obtain continuous stacks (Fig. S2). Finally,
imaging of cryosections showed image quality variations
within every single section. Consequently, 3D reconstructions
of the confocal image stacks were inundated with so much
background that REx-positive neuronal cells in the RN could
be visualized only in a few positions upon intense manipulation
and thresholding (Fig. 2 D, the same specimen as in Fig. 2, B).
The ultramicroscopy imaging revealed decreased numbers
of REx-positive neurons in the RN only on the side contra-
lateral to the prion inoculation (Fig. 2 E and Movie S3,
225-day-old Tga20 mouse). After the initial asymmetric
distribution of prions, our data demonstrate functional
defects in axonal projections of RN neurons contralaterally
to the site of prion inoculation.
Ultramicroscopy enables both superior imaging
and deep penetration into the MC area
The improved ultramicroscopy setup demonstrated several
advantages for the imaging of the MC over the confocal
microscopy. A penetration depth of up to 4.2 mm allowedCB
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A FIGURE 1 (A) Prions inoculated into
the right sciatic nerve spread along
axonal projections into the RN and the
MC. Application of AAV-REx tracer
into the spinal cord resulted in retro-
grade labeling of motor neurons in
CNS centers. The areas analyzed in
this study are shown on the images of
coronar sections taken from www.
hms.harvard.edu/ and http://biology.
clc.uc.edu/, respectively. To visualize
defects in axonal transport, the tracer
was applied shortly before the onset of
the disease (onset). (B) For the ultrami-
croscopy, the specimens placed into the
chamber with CS were moved through
light sheet obtained with cylindrical
lens. Emitted light was collected with
10 objective located at 90 to the light
sheet, let through optical filter allowing
only REx to efficiently pass and imaged
with an EMCCD camera. (C–E) 3D reconstructions of ultramicroscopy optical stacks showing REx-positive cells in spinal cord, 0.3 mm-thick stack, 225-day-
old Tga20 mouse (C); RN, 0.2 mm-thick stack, 244-day-old Tga20 mouse (D), and MC, 4.2 mm-thick stack, 242-day-old wt mouse (E). Scale bars, 100 mm.Biophysical Journal 96(8) 3390–3398
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FIGURE 2 (A) Ultramicroscopy image from 0.2 mm-
thick stack from RN of 396-day-old wt mock mouse. The
image quality is comparable to the confocal imaging (B).
(B) Confocal image of the RN, 70-day-old wt mock mouse.
(C) 3D reconstruction of 0.2 mm-thick ultramicroscopy
RN stack, the same specimen as in A. The ultramicroscopy
enables 3D reconstruction of superior quality and contain-
ing lower background as compared to the confocal one (D).
(D) 3D reconstruction of six serial confocal stacks from
RN. Because of cryosectioning, the reconstruction contains
high background. (E) 3D reconstruction of ultramicroscopy
stacks from prion-challenged Tga20 mouse. The side of the
RN contralateral to prion inoculation contains reduced
amount of REx-positive cells (arrows). Scale bars, 100 mm.the complete reconstruction of the MC area (Fig. 3 A, 273-
day-old wt mouse). The ultramicroscopy images were of
better quality as compared to the confocal ones (Fig. 3 B,
136-day-old wt mouse) in the beginning as well in the end
of 3.8 mm-thick stack (Fig. 3, C and D, the same specimen
as in Fig. 3 A). Signal/background (2.7  0.5) was
significantly higher than for the confocal images (1.2 
0.1), which was visible especially for prion-challenged
animals (Fig. 3, B–D). Ultramicroscopy generated uniform
images with a background deviation of 1.3-  0.1-fold,
which were easy to process and perform in-depth analysis.
The differing background in the confocal images (27.5- 
8.4-fold deviation between maximal and minimal brightness
in the background) as well as low signal/background seri-
ously complicated data analysis and interpretation.
Majority of cortical motor neurons demonstrate
impaired axonal transport at the onset of clinincal
prion disease
The prion inoculation into the right sciatic nerve leads to
prion accumulation in various CNS centers including spinalBiophysical Journal 96(8) 3390–3398cord, lateral vestibular nucleus, RN, hindlimb MC, and thal-
amus (22,40). We observed prion accumulation in MC and
RN of wt and Tga20 mice at the terminal stage of the disease
after i.n. inoculation (Fig. S3), which correlates with the data
on hamster (22) and murine (40) disease models. Upon inoc-
ulation in the sciatic nerve, wt and Tga20 animals demon-
strated incubation times of 168  5 and 67  2 days post
infection (dpi), respectively, until the terminal stages of the
disease. The time points of the initial clinical disease onset
were 149 dpi for wt and 59 dpi for Tga20 mice. We applied
AAV-REx before the disease onset at 136 dpi and 54 dpi for
wt and Tga20 mice, respectively (Fig. S4), and demonstrated
the accumulation of prions in the MC and RN also at the
same time points (Fig. S5). Visualization of REx positive
neurons in the MC revealed uniform images within each
experimental group (Fig. S6). The dramatic differences
were detected between prion-challenged animals and mock
controls (Fig. 4 and Fig. S6), which were consistent for
both confocal (Fig. 4 A) and ultramicroscopy imaging
(Fig. 4 B and Movie S4). Ultramicroscopy yielded images
with superior quality ready for in-depth analysis. Upon
Ultramicroscopy: Prion-Induced Effects 3395Y
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FIGURE 3 (A) 3D reconstruction of 3.8 mm-thick ultra-
microscopy stacks showing REx-positive cells in the MC
of 273-day-old wt mouse challenged with prions i.n.
(AAV-REx application at 136 days post infection). (B)
Confocal image of the MC from 264-day-old prion-in-
fected wt mouse (AAV-REx application at 136 days post
infection). (C and D) First (C) and last (D) ultramicroscopy
images from MC stack done with prion-infected wt mouse
(the same as in A). Graph coordinates indicate the distances
in micrometers. Scale bars, 100 mm.image processing, we were able to implement automated
cell-tracking and cell-positioning protocols to identify the
location and number of cells in the MC and other CNS
regions (Fig. 4 C).
To quantify the REx positive neurons in mock and prion-
challenged animals, we adapted automated label recognition
for confocal and ultramicroscopy stacks. We colocalized
REx deposits with NeuN-positive neurons in the MC and
adapted the deposit properties for REx quantification.
(Fig. 5 A). Moreover, the stacks from mock and prion-inoc-
ulated animals were combined in the single file, simulta-
neously edited and subsequently used for the quantification.
The software properties for the label recognition were addi-
tionally adjusted to the quantity of neurons in the same MC
level assessed by the staining with antibodies against
PGP9.5, a neuronal marker (Fig. S7).
As shown in Fig. 5 B, quantification of tracer-positive
neurons in the MC of wt animals by confocal microscopy re-
vealed a decrease of REx-positive neurons for 96%  4%
and 92%  11% on the side contralateral and ipsilateral to
the prion challenge (n¼ 4), respectively. Confocal and ultra-
microscopy analyses demonstrated severe impairments inretrograde axonal transport of prion-infected cortical motor
neurons as judged by their inability to express REx in the
MC neurons. Moreover, a similar 98%  0.1% and 78%
 4% decrease for the contra- and ipsilateral sides, respec-
tively, was also obtained for the Tga20 mice (Fig. 5 B).
Such a dramatic decrease of REx-positive neurons cannot
be explained simply by the cell loss in the MC. The quanti-
fication of NeuN- and PGP9.5-positive neurons in the MC
revealed no significant differences between mock controls
and prion-challenged animals (Fig. S8). Moreover, the anal-
ysis of REx-positive cells in the spinal cord revealed also no
differences between mock and prion-inoculated littermates
(Fig. S9). Because the spinal cord demonstrates the high
PrPSc content (22,40), this experiment rules out the hypoth-
esis that the observed decrease of REx-positive neurons in
the MC could be attributed to the general prion influence
on the uptake and/or expression directed by the AAV-REx.
DISCUSSION
Investigations of the biological processes in vivo, especially
of the nervous tissue containing a lot of interconnected cellsB
A
C
FIGURE 4 (A) Number of REx-posi-
tive neurons is reduced bilaterally in the
MC of i.n. prion-infected mice as
compared to mock control. Confocal
imaging done with 288-day-old mock
and 264-day-old prion-challenged wt
mice (AAV-REx application at 136
days post infection). Scale bar, 100 mm.
(B) 3D reconstructions of 0.2 mm-thick
ultramicroscopy stacks also reveal the
reduction of traced neurons in the MC
upon prion challenge. The imaging
was done on 244-day-old mock and
225-day-old i.n. prion-challenged
Tga20 mice (AAV-REx application
at 54 days post infection). Scale bar,
100 mm. (C) 3D cell position and image
analysis of the data from Fig. 3 C are
shown in the MC of mock and prion-
challenged mice (the same specimens
as in B).Biophysical Journal 96(8) 3390–3398
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FIGURE 5 (A) REx deposits colocalize with NeuN-posi-
tive neurons in the MC of mock-challenged mouse. The
deposit sizes allow distinguishing the REx-positive
neurons from background fluorescence. Prion-infected
animals show dramatically less labeled neurons. Scale
bars, 100 mm. (B) Graph of the REx-positive neuron quan-
tification. Despite the difference in the incubation times
(168.8 days post infection, dpi and 67.9 dpi for wt and
Tga20 mice, respectively), both mouse lines showed
similar reduction of REx-positive neurons. Wt demon-
strates 96%  4% impaired neurons on the contralateral
side and 92%  11% on the ipsilateral side as evaluated
on confocal images, (n ¼ 4), and 93%  7% and 87 
6%, respectively, as evaluated on 0.25 mm-thick ultrami-
croscopy stacks (n ¼ 5). Tga20 shows 98%  0.1% and
78%  4% impaired neurons, on the contra- and ipsilateral
sides, respectively, as evaluated on 0.25 mm-thick ultrami-
croscopy stacks (n ¼ 3). ***p < 0.0001 **p ¼ 0.0005
(unpaired t-test).with long projections, often requires imaging methods
combining deep penetration and high resolution. The areas
of interest in the CNS are frequently larger than the maximal
penetration depth of 0.15 mm, currently achieved by laser-
scanning confocal microscopy or objective-coupled planar
illumination microscopy. The first ultramicroscopy protocol
combined R2mm-deep penetration into the specimen with
a cellular resolution for embryos or was restricted to
0.41 mm penetration depth for mice not older than 35 days
(9). Consequently, this method could not be used to study
animal models of infectious or neurodegenerative diseases.
The ultramicroscopy imaging technique presented in this
work enabled the effective visualization and 3D analysis in
adult mouse CNS up to 400 days of age. The improved ultra-
microscopy protocol allowed remarkable penetration into the
specimen beyond 4 mm and thereby establishes this imaging
technique as the method of choice for studying such large
CNS areas as MC or spinal cord. Along with the deep pene-
tration, this method keeps the resolution on the confocal
microscopy level without sectioning side effects. Areas of
interest in MC or spinal cord are long (1.5–2 cm), making
serial sectioning and analysis extremely laborious. Conse-
quently, simplified approaches are used, like the imagingBiophysical Journal 96(8) 3390–3398of every third MC section, which excludes a meaningful
3D reconstruction. A complete reconstruction of the
confocal image stacks from the entire MC is extremely diffi-
cult to process due to the shifts incurred from each histolog-
ical section, distracting background auto fluorescence, and
simply big dimensions of the center implying a lot of
sectioning.
The ultramicroscopy yielded images of high quality,
which did not require any expensive and time-consuming
image processing for specimen analysis and 3D reconstruc-
tion. Simple rescaling algorithms similar to previous reports
(41) were enough to reduce background and remove shad-
owing artifacts. The ultramicroscopy can be accomplished
within hours producing stacks suitable for immediate recon-
struction and analysis making this technique also a suitable
choice for analysis of statistically significant animal groups.
Such analysis can be done with free software (ImageJ) or
with more expensive and sophisticated software packages
(Volocity), which enables further in-depth study, analysis,
and quantification.
In contrast to the MC and spinal cord, imaging of the RN
could be accomplished with confocal microscopy; however,
sectioning side effects also largely compromises 3D
Ultramicroscopy: Prion-Induced Effects 3397reconstruction of the whole area. Here we demonstrate that
our ultramicroscopy protocol also represents a valuable tech-
nique for the analysis of small and nonuniformly built
centers, with resolution comparable to confocal microscopy
and suitable for the effective 3D reconstruction of a whole
brain center.
An alternative method, intravital deep-tissue multiphoton
microscopy (37), revealed high resolution and 0.5 mm
optical penetration depth in the MC, but yielded signal/back-
ground comparable to confocal imaging (2.0  0.1) with
high background deviations of 5.8-  1.7-fold (Fig. S10).
Moreover, due to the high background, the RN and spinal
cord tissues could not be imaged with this technique.
The combination of tracing, as a functional assay for the
retrograde axonal transport, and ultramicroscopy, as an
imaging technique, were successfully applied to study motor
neurons in prion disease. We demonstrated for the first time,
to our knowledge, that impairments of the transport
processes in rubrospinal and corticospinal motor neurons
correlated with the onset of clinical prion disease. Damaged
neurons appeared unilaterally in the RN after initial prion
distribution of prions upon unilateral challenge (22). The
RN is an important movement coordination center in
rodents, which partially lost its role in higher developed
animal species, like primates or humans (42). The MC, on
the other hand, is involved in the voluntary movement of
both rodents and humans. The delivery of REx into the
cell bodies was blocked in 78–98% of motor neurons due
to functional impairments in retrograde transport. We
observed similar decrease of REx-positive neurons for two
different mouse lines despite dramatic differences in the
incubation times. Such effects were observed before the
onset of disease symptoms including ataxia and hind limb
paralysis. Because the decrease of neuronal cells could not
be observed on stainings with the neuronal marker NeuN
in MC of prion-infected animals (Fig. 5 A, and Fig. S7 and
Fig. S8), the phenomenon cannot be attributed to neuronal
loss but rather to the functional impairments in retrograde
axonal transport in living neurons. This conclusion is also
supported by the fact that there is no difference of REx-posi-
tive cells in the gray matter of the spinal cord, the CNS center
also infected by the prions. Recent studies in experimental
models for prion diseases (43,44) as well as in sporadic
CJD patients (15,16) suggest the role of the axonal defects
in prion pathogenesis supporting the evidence for the trans-
port impairments demonstrated in this work. These studies,
however, were restricted to the description of either prion
protein deposits (44) or changes in the axonal structure
during the disease (16). The data presented in this work
provide the first direct evidence, to our knowledge, proving
that prion disease is associated with severe defects in the
axonal transport of cortical motor neurons and establishes
the transport impairments as a possible mechanism for the
prion-mediated neurodegeneration. The role of axonal trans-
port as a common pathogenesis target was demonstrated forvarious neurodegenerative diseases (1) including amyotro-
phic lateral sclerosis (45) and Alzheimer’s disease (46).
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